跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARTEOPTIC PF 2% COLIRIO EN SOLUCION DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ARTEOPTIC PF 2% COLIRIO EN SOLUCION DE LIBERACION PROLONGADA
Approved
STANDARD
ARTEOPTIC PF 2% COLIRIO EN SOLUCION DE LIBERACION PROLONGADA
Bausch + Lomb Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 23, 2024
Approval ID
da82ef83bc67b377
Company
Bausch + Lomb Ireland Limited
Type
Standard
Approval Details
Approval Id
da82ef83bc67b377
Drug Cima Aemps Name
ARTEOPTIC PF 2% COLIRIO EN SOLUCION DE LIBERACION PROLONGADA
Register Number
89580
Holder Company Name
Bausch + Lomb Ireland Limited
Marketing Company Name
Bausch & Lomb S.A.
Holder Company Detail Path
/organization/bausch-lomb-ireland-limited
Authorization Date
2024-05-23
Dosage Form
COLIRIO EN SOLUCION DE LIBERACION PROLONGADA
Dose
20 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
No
Company Name
Bausch + Lomb Ireland Limited
Company Detail Path
/organization/bausch-lomb-ireland-limited
Company Information
Pharmaceutical Company Name
BAUSCH + LOMB IRELAND LIMITED
Country Name
Ireland
City Name
waterford,country_ie
Address
BAUSCH + LOMB VISION CARE
Active Ingredients
CARTEOLOL HIDROCLORURO
20 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 23, 2024
Approval ID
da82ef83bc67b377
Type
Standard
Back to CIMA-AEMPS Approvals